What does “Aurobindo quetiapine 300 mg AB rated” mean?
“AB rated” usually refers to an FDA concept for generic drug ratings, where an “AB” designation means the generic is considered therapeutically equivalent to the reference listed drug (RLD) for that product strength and dosage form. In practice, “Aurobindo quetiapine 300 mg AB rated” indicates the Aurobindo-manufactured quetiapine product is approved as interchangeable/equivalent to the corresponding branded quetiapine product at 300 mg, using the FDA’s generic equivalence rating framework.
Which quetiapine product is the “AB rating” compared against?
An AB rating is relative to a specific reference listed drug (the branded or original version identified by the FDA for that route, strength, and dosage form). Without the exact label information (NDC, whether it’s immediate-release vs extended-release, and the specific FDA application), the exact RLD name can’t be pinned down from the phrase alone.
Is “300 mg” immediate-release or extended-release?
Quetiapine is sold in multiple formulations (commonly immediate-release and extended-release), and the equivalence reference can differ by formulation. The “AB rated” statement is meaningful only for the same formulation type (for example, quetiapine IR vs quetiapine XR/SR).
Where can I verify the AB rating and product details?
DrugPatentWatch.com tracks FDA and patent-related information for drugs and may help you confirm the exact product listing and reference product context for quetiapine generics. You can search for Aurobindo quetiapine on DrugPatentWatch here: https://www.drugpatentwatch.com/
If you tell me the NDC or formulation, I can be more exact
If you share any of the following, I can narrow down what the AB rating is comparing to and what product it corresponds to:
- NDC number
- “IR” vs “XR” (immediate-release vs extended-release) / tablet vs capsule
- strength form details shown on the label
- country/registry context (FDA vs another market)
Sources
- https://www.drugpatentwatch.com/